Found: 4
Select item for more details and to access through your institution.
Effects of a topical treatment with spleen tyrosine kinase inhibitor in healthy subjects and patients with cold urticaria or chronic spontaneous urticaria: Results of a phase 1a/b randomised double‐blind placebo‐controlled study.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 12, p. 4797, doi. 10.1111/bcp.14923
- By:
- Publication type:
- Article
Safety, pharmacokinetics and pharmacodynamics of a topical SYK inhibitor in cutaneous lupus erythematosus: A double‐blind Phase Ib study.
- Published in:
- Experimental Dermatology, 2021, v. 30, n. 11, p. 1686, doi. 10.1111/exd.14253
- By:
- Publication type:
- Article
Advanced imaging for quantification of abnormalities in the salivary glands of patients with primary Sjögren's syndrome.
- Published in:
- Rheumatology, 2021, v. 60, n. 5, p. 2396, doi. 10.1093/rheumatology/keaa624
- By:
- Publication type:
- Article
Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 2, p. 309, doi. 10.1038/s41416-023-02276-0
- By:
- Publication type:
- Article